GLYCOLIPID CHANGES DURING CHEMICAL HEPATOCARCINOGENESIS
GLYCOLIPID CHANGES DURING CHEMICAL HEPATOCARCINOGENESIS
批准号:
3460248
负责人:
GARY K OSTRANDER
金额:
$8.62万
依托单位国家:
美国
项目类别:
财政年份:
1990
资助国家:
美国
项目状态:
已结题
起止时间:
1990-09-01 至 1995-08-31
关键词:
carbohydrate structure chemical carcinogen chemical carcinogenesis chemical related neoplasm /cancer dosage embryo /fetus cell /tissue glycolipids glycosphingolipids histopathology lipid biosynthesis liver neoplasms liver regeneration nitrosoguanidines preneoplastic state tissue /cell culture trout /salmon
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Glycosphingolipids (glycolipids) are membrane bound cell surface antigens
occurring in nearly all vertebrate tissues. Structural modifications of
the carbohydrate moiety were originally observed in association with end-
stage tumorigenesis. Subsequently, these changes were shown to appear
during a premalignant stage of chemical carcinogenesis. Thus, glycolipid
alterations may be of functional significance during chemical
carcinogenesis.
Proposed herein are studies to enhance understanding of the nature of
glycolipid alterations during chemical hepatocarcinogenesis. A departure
from traditional carcinogenesis studies entails utilization of rainbow
trout. Studies with trout will permit exploitation of novel aspects of
this model system. First generations experiments include whole animal
tumor induction studies with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) to
elucidate specific glycolipid changes throughout carcinogenesis. These
experiments will utilize high doses of carcinogen to insure adequate tumor
tissue for characterizing glycolipid alterations. Second generation
experiments will follow traditional complete carcinogenesis as well as
initiation/promotion regiments with MNNG. Sensitive probes developed from
the first generation experiments will be used to elucidate the ontogeny of
these alterations. Coincident with these experiments will be detailed
study of the histology of developing lesions (preneoplastic foci through
end-stage tumors). Thus, it will be possible ascertain the specificity of
particular lesion types with altered glycolipid profiles. Glycolipids will
be isolated and examined from normal and premalignant tissues, tumors, and
cell lines as well as fetal, developing, and regenerating liver. From such
comparisons the nature and extent of glycolipid alterations will be
determined. The enzymatic lesion(s) associated with these alterations will
then be investigated to ascertain the manner in which such modifications in
carbohydrate structure are mediated.
Finally, information collected concerning glycolipid changes during
chemical carcinogenesis in the rainbow trout will be carefully compared and
contrasted with published mammalian studies to provide a broader base for
further understanding of the significant role of glycolipids during
carcinogenesis in all vertebrate species.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ADMINISTRATIVE CORE
-
批准号:8357167
-
项目类别:
-
资助金额:$46.74万
-
财政年份:2011
-
负责人:GARY K OSTRANDER
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:8166173
-
项目类别:
-
资助金额:$80.0万
-
财政年份:2010
-
负责人:GARY K OSTRANDER
-
依托单位:
Research Outcomes Accelerating Discoveries for Medical Applications and Practice
-
批准号:7918440
-
项目类别:
-
资助金额:$88.03万
-
财政年份:2009
-
负责人:GARY K OSTRANDER
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7959172
-
项目类别:
-
资助金额:$62.09万
-
财政年份:2009
-
负责人:GARY K OSTRANDER
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7725313
-
项目类别:
-
资助金额:$53.42万
-
财政年份:2008
-
负责人:GARY K OSTRANDER
-
依托单位:
ANIMAL FACILITY IMPROVEMENT PROJECTS
-
批准号:7715312
-
项目类别:
-
资助金额:$76.68万
-
财政年份:2008
-
负责人:GARY K OSTRANDER
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7715303
-
项目类别:
-
资助金额:$19.6万
-
财政年份:2008
-
负责人:GARY K OSTRANDER
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7561544
-
项目类别:
-
资助金额:$51.68万
-
财政年份:2007
-
负责人:GARY K OSTRANDER
-
依托单位:
ADMINISTRATIVE CORE
-
批准号:7609594
-
项目类别:
-
资助金额:$63.64万
-
财政年份:2007
-
负责人:GARY K OSTRANDER
-
依托单位:
UNIVERSITY OF HAWAII - ASIA-PACIFIC SCHOOL OF PUBLIC HEALTH
-
批准号:7404148
-
项目类别:
-
资助金额:$9.92万
-
财政年份:2005
-
负责人:GARY K OSTRANDER
-
依托单位:
Endowment in Cardivascular Science
-
批准号:7406258
-
项目类别:
-
资助金额:$31.25万
-
财政年份:2002
-
负责人:GARY K OSTRANDER
-
依托单位:
University of Hawaii Health Disparities Research Endowment
-
批准号:7213026
-
项目类别:
-
资助金额:$31.25万
-
财政年份:2002
-
负责人:GARY K OSTRANDER
-
依托单位:
Research Outcomes Accelerating Discoveries for Medical Applications and Practice
-
批准号:7288320
-
项目类别:
-
资助金额:$270.45万
-
财政年份:1997
-
负责人:GARY K OSTRANDER
-
依托单位:
Research Outcomes Accelerating Discoveries for Medical Applications and Practice
-
批准号:7485621
-
项目类别:
-
资助金额:$287.85万
-
财政年份:1997
-
负责人:GARY K OSTRANDER
-
依托单位:
Research Outcomes Accelerating Discoveries for Medical Applications and Practice
-
批准号:7922073
-
项目类别:
-
资助金额:$282.79万
-
财政年份:1997
-
负责人:GARY K OSTRANDER
-
依托单位:
Research Outcomes Accelerating Discoveries for Medical Applications and Practice
-
批准号:7936701
-
项目类别:
-
资助金额:$35.29万
-
财政年份:1997
-
负责人:GARY K OSTRANDER
-
依托单位:
RCMI CLINICAL RESEARCH INFRASTRUCTURE INITIATIVE (RCRII)
-
批准号:7127715
-
项目类别:
-
资助金额:$177.1万
-
财政年份:1997
-
负责人:GARY K OSTRANDER
-
依托单位:
Research Outcomes Accelerating Discoveries for Medical Applications and Practice
-
批准号:7135124
-
项目类别:
-
资助金额:$234.45万
-
财政年份:1997
-
负责人:GARY K OSTRANDER
-
依托单位:
RCMI CLINICAL RESEARCH INFRASTRUCTURE INITIATIVE (RCRII)
-
批准号:7256535
-
项目类别:
-
资助金额:$156.76万
-
财政年份:1997
-
负责人:GARY K OSTRANDER
-
依托单位:
Research Outcomes Accelerating Discoveries for Medical Applications and Practice
-
批准号:7679731
-
项目类别:
-
资助金额:$290.7万
-
财政年份:1997
-
负责人:GARY K OSTRANDER
-
依托单位:
海外基金